NCT05562193

Brief Summary

The purpose of this study is to demonstrate that integration of exercise intervention into standard post-cancer directed treatment care will improve patient reported pain, decrease the need for medications to manage chronic pain and improve functional and psychosocial outcomes in survivors of cancers in children and adolescents. Our central hypothesis is that integration of exercise interventions into standard post-cancer directed treatment care will be acceptable and feasible while improving patients' pain, decreasing the cumulative dose of pain medication and improving patients' functional and psychosocial outcomes as compared to patients who only receive standard post-cancer directed treatment care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 30, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

September 30, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 11, 2025

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

2.4 years

First QC Date

September 26, 2022

Last Update Submit

May 8, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Acceptability of the intervention

    The number of participants approached who agree to participate in the study

    Baseline

  • Feasibility of the intervention

    The number of participants randomized to the physical activity program intervention coupled with standard post-cancer directed treatment care who complete at least 50% of the physical activity intervention.

    Baseline to week 16

Secondary Outcomes (8)

  • Measure changes in chronic pain levels

    Baseline, week 8 and week 16

  • Measure changes in cumulative dose of pain medications

    Baseline, week 4, week 8, week 12 and week 16

  • Measure changes in patient reported outcomes

    Baseline, week 8 and week 16

  • Measure changes in physical activity level

    Baseline, week 8 and week 16

  • Measure changes in patient functional outcomes (6-min walking test)

    Baseline and week 16

  • +3 more secondary outcomes

Study Arms (2)

Physical activity intervention coupled with standard post-cancer directed treatment care group

EXPERIMENTAL
Behavioral: Physical activity intervention coupled with standard post-cancer directed treatment care

Standard post-cancer directed treatment care control group

OTHER
Other: Standard post-cancer directed treatment care control

Interventions

CCS will participate in a 16-week physical activity program. CCS will be instructed to start with a session duration of \<15-min, three days per week at low intensity (e.g., activities expending \>1.5 to 3 METs or intensity \<5 on a scale of 0 to 10). Any type of physical activity will be acceptable. The program will be individualized, and activity increased according to patients' health status, results from the physical function assessment, and most recent week's achieved physical activities. The program will include support calls and texts from research staff (exercise physiologist). The program will be modified and adapted during support calls or texts, including frequency, intensity, time and type to maximize CCS' success. CCS will receive a Fitbit at the beginning of the intervention.

Physical activity intervention coupled with standard post-cancer directed treatment care group

CCS in the control group will not participate in a 16-week physical activity program and will not receive support calls or texts. Physical activity advice according to the Children's Oncology Group Guidelines for Diet and Physical Activity recommendations and the International Pediatric Oncology Exercise Guidelines will be offered to CCS following completion of 16-week follow-up. Moreover, CCS will receive a Fitbit following completion of 16-week follow-up

Standard post-cancer directed treatment care control group

Eligibility Criteria

Age10 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Male and female CCS diagnosed with any type of cancer
  • CCS who have completed all standard/planned cancer treatment and are stable at the time of recruitment
  • CCS are \< 1-year post cancer therapy
  • CCS who have chronic pain (pain will be self-reported by the participant, will have to be ≥1 on a scale of 10 and lasting for 3 months or longer)
  • CCS who are age between 10 and 17 years old at the time of enrollment
  • CCS who are and who are not non-ambulatory/wheelchair bound.
  • CCS and parent/legal guardian must be able to speak, read and understand the English language
  • CCS's parent or legal guardian must be able to provide and understand informed consent
  • CCS must be able to provide and understand assent
  • CCS must be able to attend three visits (baseline, 8 and 16-week follow-up) at the Penn State Health Children's Hospital
  • CCS and parent/legal guardian must have access to a computer, smartphone or tablet
  • Note: The agreement of the attending oncologist will be required for the participation of CCS eligible for this study.

You may not qualify if:

  • CCS who have not completed all standard/planned cancer treatment and/or not in complete remission at the time of recruitment
  • CCS who are \> 1-year post cancer therapy
  • CCS who are \< 10 years old and \> 17 years old at the time of enrollment
  • CCS who have history of refractory or recurrent cancer
  • CCS or their parent/legal guardian who are unable to speak, read, and understand the English language
  • CCS who are unable to access and complete online questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State Health Children's Hospital

Hershey, Pennsylvania, 17033, United States

Location

Study Officials

  • Smita Dandekar, MD

    Penn State College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Smita Dandekar, MD

Study Record Dates

First Submitted

September 26, 2022

First Posted

September 30, 2022

Study Start

September 30, 2022

Primary Completion

March 11, 2025

Study Completion

March 11, 2025

Last Updated

May 14, 2025

Record last verified: 2025-05

Locations